Tonix Pharmaceuticals (TNXP) Q2 2024 Earnings
TNXP·Reported August 16, 2024·Before market open
Tonix Pharmaceuticals reported Q2 2024 revenue of $2.2M, missed analyst consensus of $3.6M by $1.4M. Diluted EPS came in at $-1928.00, missed the $-991.00 consensus by $937.00.
Revenue
$2.2Mmissed by $1.4M
Consensus: $3.6MDiluted EPS
$-1928.00missed by $937.00
Consensus: $-991.00
Financial Snapshot
Trailing eight quarters through Q2 2024
Q2 2024 Earnings FAQ
Common questions about Tonix Pharmaceuticals's Q2 2024 earnings report.
Tonix Pharmaceuticals (TNXP) reported Q2 2024 earnings on August 16, 2024 before market open.
Tonix Pharmaceuticals reported revenue of $2.2M and diluted EPS of $-1928.00 for Q2 2024.
Revenue missed the consensus estimate of $3.6M by $1.4M. EPS missed the consensus estimate of $-991.00 by $937.00.
You can read the 10-Q periodic report (0001999371-24-010281) directly on SEC EDGAR. The filing index links above go to sec.gov.